management of immunotherapy toxicity in gynecological cancers
Published 6 years ago • 51 plays • Length 1:08Download video MP4
Download video MP3
Similar videos
-
2:22
immunotherapy toxicities and checkpoint inhibitor therapy
-
1:43
managing toxicity from immunotherapy
-
0:43
the rarer toxicities of immunotherapy
-
8:42
management of immune-related adverse events in ici therapy
-
1:40
be vigilant: management of checkpoint inibitor toxicities
-
8:17
immune checkpoint inhibitors
-
1:12:46
immunotherapy treatment and survivorship: precision medicine in action
-
15:51
introduction to immunotherapy (immunotherapy documentary part i)
-
0:50
clinical considerations for toxicity management and survivorship
-
36:20
gynecologic cancer immunotherapy: new potential in gynecologic cancers
-
14:42
managing toxicities associated with immune-checkpoint inhibitors
-
5:49
immunotherapy toxicity and duration of therapy
-
1:57
managing the adverse events of immune checkpoint inhibitors
-
59:13
improving the management of cardiac immune-related adverse events in patients with cancer
-
21:59
monitoring, managing, and mitigating immune-related adverse events
-
40:43
can we therapeutically harness the immune system for gynecological cancers?
-
3:30
side effects of immune checkpoint inhibitors
-
42:12
immunotherapy for gynecologic cancers, with kunle odunsi
-
48:45
gynecologic cancer education: immunotherapy & you
-
2:36
immunotherapy in gynecological cancers: current and future landscape
-
31:15
keynote lecture: managing side effects of io agents
-
27:43
targeting the immune system with checkpoint inhibitors